TY - JOUR
T1 - Using Stochastic modelling to identify unusual continuous glucose monitor measurements and behaviour, in newborn infants
AU - Signal, Matthew
AU - Le Compte, Aaron
AU - Harris, Deborah
AU - Weston, Phil J.
AU - Harding, Jane E.
AU - Chase, J. G.
AU - CHYLD Study Team
AU - Alsweiler, Jane
AU - Chase, Geoff
AU - Harding, Jane
AU - Harris, Deborah
AU - Thompson, Ben
AU - Wouldes, Trecia
AU - Ansell, Judith
AU - Anstice, Nicola
AU - Arthur, Jo
AU - Bevan, Coila
AU - Bluett, Kate
AU - Campbell, Ellen
AU - Chakraborty, Arijit
AU - Crawford, Tineke
AU - Frost, Karen
AU - Gamble, Greg
AU - Jacobs, Rob
AU - Jones, Kelly
AU - Le Compte, Aaron
AU - Martin, Sapphire
AU - Matheson, Gill
AU - McKnight, Grace
AU - McQuoid, Christina
AU - Paynter, Janine
AU - Rogers, Jenny
AU - Signal, Matthew
AU - Stewart, Heather
AU - Timmings, Anna
AU - Young, Rebecca
AU - Yu, Sandy
N1 - © 2012 Signal et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
PY - 2012/8/6
Y1 - 2012/8/6
N2 - Background: Abnormal blood glucose (BG) concentrations have been associated with increased morbidity and mortality in both critically ill adults and infants. Furthermore, hypoglycaemia and glycaemic variability have both been independently linked to mortality in these patients. Continuous Glucose Monitoring (CGM) devices have the potential to improve detection and diagnosis of these glycaemic abnormalities. However, sensor noise is a trade-off of the high measurement rate and must be managed effectively if CGMs are going to be used to monitor, diagnose and potentially help treat glycaemic abnormalities.Aim: To develop a tool that will aid clinicians in identifying unusual CGM behaviour and highlight CGM data that potentially need to be interpreted with care.Methods: CGM data and BG measurements from 50 infants at risk of hypoglycaemia were used. Unusual CGM measurements were classified using a stochastic model based on the kernel density method and historical CGM measurements from the cohort. CGM traces were colour coded with very unusual measurements coloured red, highlighting areas to be interpreted with care. A 5-fold validation of the model was Monte Carlo simulated 25 times to ensure an adequate model fit.Results: The stochastic model was generated using ~67,000 CGM measurements, spread across the glycaemic range ~2-10 mmol/L. A 5-fold validation showed a good model fit: the model 80% confidence interval (CI) captured 83% of clinical CGM data, the model 90% CI captured 91% of clinical CGM data, and the model 99% CI captured 99% of clinical CGM data. Three patient examples show the stochastic classification method in use with 1) A stable, low variability patient which shows no unusual CGM measurements, 2) A patient with a very sudden, short hypoglycaemic event (classified as unusual), and, 3) A patient with very high, potentially un-physiological, glycaemic variability after day 3 of monitoring (classified as very unusual).Conclusions: This study has produced a stochastic model and classification method capable of highlighting unusual CGM behaviour. This method has the potential to classify important glycaemic events (e.g. hypoglycaemia) as true clinical events or sensor noise, and to help identify possible sensor degradation. Colour coded CGM traces convey the information quickly and efficiently, while remaining computationally light enough to be used retrospectively or in real-time.
AB - Background: Abnormal blood glucose (BG) concentrations have been associated with increased morbidity and mortality in both critically ill adults and infants. Furthermore, hypoglycaemia and glycaemic variability have both been independently linked to mortality in these patients. Continuous Glucose Monitoring (CGM) devices have the potential to improve detection and diagnosis of these glycaemic abnormalities. However, sensor noise is a trade-off of the high measurement rate and must be managed effectively if CGMs are going to be used to monitor, diagnose and potentially help treat glycaemic abnormalities.Aim: To develop a tool that will aid clinicians in identifying unusual CGM behaviour and highlight CGM data that potentially need to be interpreted with care.Methods: CGM data and BG measurements from 50 infants at risk of hypoglycaemia were used. Unusual CGM measurements were classified using a stochastic model based on the kernel density method and historical CGM measurements from the cohort. CGM traces were colour coded with very unusual measurements coloured red, highlighting areas to be interpreted with care. A 5-fold validation of the model was Monte Carlo simulated 25 times to ensure an adequate model fit.Results: The stochastic model was generated using ~67,000 CGM measurements, spread across the glycaemic range ~2-10 mmol/L. A 5-fold validation showed a good model fit: the model 80% confidence interval (CI) captured 83% of clinical CGM data, the model 90% CI captured 91% of clinical CGM data, and the model 99% CI captured 99% of clinical CGM data. Three patient examples show the stochastic classification method in use with 1) A stable, low variability patient which shows no unusual CGM measurements, 2) A patient with a very sudden, short hypoglycaemic event (classified as unusual), and, 3) A patient with very high, potentially un-physiological, glycaemic variability after day 3 of monitoring (classified as very unusual).Conclusions: This study has produced a stochastic model and classification method capable of highlighting unusual CGM behaviour. This method has the potential to classify important glycaemic events (e.g. hypoglycaemia) as true clinical events or sensor noise, and to help identify possible sensor degradation. Colour coded CGM traces convey the information quickly and efficiently, while remaining computationally light enough to be used retrospectively or in real-time.
KW - Classify
KW - Continuous Glucose Monitor
KW - Glycaemia
KW - Intensive care unit
KW - Neonatal
UR - http://www.scopus.com/inward/record.url?scp=84864519217&partnerID=8YFLogxK
U2 - 10.1186/1475-925X-11-45
DO - 10.1186/1475-925X-11-45
M3 - Article
C2 - 22866980
AN - SCOPUS:84864519217
SN - 1475-925X
VL - 11
JO - BioMedical Engineering Online
JF - BioMedical Engineering Online
M1 - 45
ER -